Siren, L.L.C. Portfolio
Auto-discovered 13F filer (Top-2000 by latest reported value).
SEC 13F CIK: 0002005245
What is a 13F filing? Who files one and when · What 13F filings can't tell you
Q4 2024 · 117 positions · Total reported value $2.26B · Top-10 concentration 48.6% · Updated 2026-10-18
Last updated: 2026-10-18 · Source: SEC EDGAR Form 13F-HR
Turnover: 55.7% · 15 new · 36 cut · 22 exited
Active Share (vs S&P 500): 97.6% · vs QQQ: 97.6% — share of the book that differs from index weights (higher = more active) · ranking
Est. Qtr Return (Q2 2026 → Q3 2026): -13.5% · vs SPY -15.6% · Prev Value $4.93B — last quarter positions weighted by this quarter price moves · ranking
Est. QTD Return (Q3 2026 → newest close): -4.2% · vs SPY -6.4% · Latest Value $4.21B — latest reported positions valued at quarter-to-date price moves (still in progress) · ranking
In its Q4 2024 13F filing, Siren, L.L.C. disclosed 117 equity positions with a combined reported value of $2.26B. The filing implies a moderately concentrated portfolio: its ten largest positions account for 48.6% of reported value. HoldingsHub classifies the profile as Mid / Health Tilt / High Turnover.
The largest disclosed positions as of Q4 2024 were SRRK ($399.79M), ONC ($120.75M), KYMR ($119.47M). By sector, the heaviest allocations are Health Care 73.4%, Technology 4.8%. Versus the prior quarter, allocation shifted toward Health Care (+3.9pp) and away from Other (-4.6pp).
Versus the prior quarter, Siren, L.L.C. opened 15 new positions, trimmed 36 and fully exited 22, a turnover rate of 55.7% of positions. The portfolio's overlap with the prior quarter was 72% of names.
The largest new positions opened in Q4 2024 were SEPN ($50.44M), MDGL ($38.86M), APGE ($33.85M).
Of the 22 positions fully exited versus the prior quarter, the largest were LBPH ($30.10M), BHVN ($14.17M), NGNE ($7.38M).
Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.
New Positions (Q4 2024)
- SEPN Septerna, Inc. · $50.44M
- MDGL MADRIGAL PHARMACEUTICALS INC · $38.86M
- APGE APOGEE THERAPEUTICS INC · $33.85M
- BCYC BICYCLE THERAPEUTICS PLC · $25.75M
- STOK Stoke Therapeutics, Inc. · $22.06M
- SLNO SOLENO THERAPEUTICS INC · $15.81M
- UPB UPSTREAM BIO INC COM · $13.15M
- TRVI TREVI THERAPEUTICS INC · $11.97M
Fully Exited (vs previous quarter)
- LBPH LONGBOARD PHARMACEUTICALS IN · prev qtr: $30.10M
- BHVN BIOHAVEN LTD · prev qtr: $14.17M
- NGNE NEUROGENE INC · prev qtr: $7.38M
- SYRS SYROS PHARMACEUTICALS INC · prev qtr: $5.56M
- NVCR NOVOCURE LTD · prev qtr: $5.48M
- ANRO ALTO NEUROSCIENCE INC · prev qtr: $4.48M
- AGEN Agenus Inc · prev qtr: $4.25M · history
- ADCT ADC THERAPEUTICS SA SHS · prev qtr: $3.66M
Insider Transactions (Form 4)
Latest Siren, L.L.C. buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.
No Form 4 filings for this fund yet — when its ownership in a stock crosses 10%, buys and sells are filed here within two business days.
Fund Profile
Siren, L.L.C. files quarterly US equity holdings with the SEC on Form 13F. Its latest filing (Q2 2026) lists 116 positions worth $4.93B in total. HoldingsHub carries 8 quarters of its filings (Q3 2024–Q2 2026).
Portfolio Structure
- 116 positions · $4.93B reported value (Q2 2026)
- Top 10 holdings = 44.8% of reported value
- Largest position: SRRK (SCHOLAR ROCK HLDG CORP) at 10.7%
- Average position size: $42.48M
Sector Tilt
- Health Care 92.0%
- Information Technology 4.5%
- Consumer Discretionary 1.2%
- (classified holdings cover 99% of value)
Quarterly Activity
- Q2 2026: 25 new, 32 added, 21 reduced, 9 exited
- 38 positions unchanged
Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.
Sector Allocation
| # | Company | Shares | Value | Weight | Allocation | Change |
|---|---|---|---|---|---|---|
| 1 |
|
9.25M | $399.79M | 17.70% | Reduce | |
| 2 |
|
653.72K | $120.75M | 5.35% | Add | |
| 3 |
|
2.97M | $119.47M | 5.29% | Hold | |
| 4 |
|
2.82M | $89.87M | 3.98% | Add | |
| 5 |
|
1.61M | $82.30M | 3.64% | Add | |
| 6 |
|
115.05K | $70.75M | 3.13% | Reduce | |
| 7 |
|
3.27M | $57.01M | 2.52% | Add | |
| 8 |
|
2.90M | $54.55M | 2.42% | Add | |
| 9 |
|
2.10M | $53.86M | 2.38% | Add | |
| 10 |
|
2.20M | $50.44M | 2.23% | New | |
| 11 |
|
3.00M | $50.33M | 2.23% | Reduce | |
| 12 |
|
1.38M | $49.78M | 2.20% | Hold | |
| 13 |
|
4.40M | $46.60M | 2.06% | Add | |
| 14 |
|
3.75M | $46.39M | 2.05% | Reduce | |
| 15 |
|
297.32K | $40.93M | 1.81% | Reduce | |
| 16 |
|
125.94K | $38.86M | 1.72% | New | |
| 17 |
|
9.97M | $36.39M | 1.61% | Hold | |
| 18 |
|
747.33K | $33.85M | 1.50% | New | |
| 19 |
|
784.41K | $32.98M | 1.46% | Add | |
| 20 |
|
1.13M | $32.78M | 1.45% | Reduce | |
| 21 |
|
758.47K | $32.08M | 1.42% | Reduce | |
| 22 |
|
1.35M | $31.75M | 1.41% | Add | |
| 23 |
|
743.77K | $29.16M | 1.29% | Hold | |
| 24 |
|
38.92M | $28.80M | 1.27% | Hold | |
| 25 |
|
1.84M | $25.75M | 1.14% | New | |
| 26 |
|
571.55K | $25.00M | 1.11% | Reduce | |
| 27 |
|
299.99K | $24.56M | 1.09% | Hold | |
| 28 |
|
1.61M | $24.00M | 1.06% | Hold | |
| 29 |
|
8.86M | $22.23M | 0.98% | Hold | |
| 30 |
|
2.00M | $22.06M | 0.98% | New | |
| 31 |
|
3.33M | $20.35M | 0.90% | Hold | |
| 32 |
|
734.34K | $19.61M | 0.87% | Add | |
| 33 |
|
2.83M | $19.48M | 0.86% | Hold | |
| 34 |
|
402.32K | $18.93M | 0.84% | Reduce | |
| 35 |
|
834.03K | $17.00M | 0.75% | Hold | |
| 36 |
|
418.83K | $15.94M | 0.71% | Hold | |
| 37 |
|
351.82K | $15.81M | 0.70% | New | |
| 38 |
|
1.10M | $15.23M | 0.67% | Hold | |
| 39 |
|
3.75M | $15.00M | 0.66% | Add | |
| 40 |
|
1.21M | $14.75M | 0.65% | Hold | |
| 41 |
|
800.00K | $13.15M | 0.58% | New | |
| 42 |
|
2.91M | $11.97M | 0.53% | New | |
| 43 |
|
1.34M | $11.67M | 0.52% | Hold | |
| 44 |
|
6.60M | $11.42M | 0.51% | Add | |
| 45 |
|
490.45K | $11.07M | 0.49% | Add | |
| 46 |
|
572.24K | $10.25M | 0.45% | Hold | |
| 47 |
|
23.00K | $9.69M | 0.43% | Add | |
| 48 |
|
175.00K | $9.37M | 0.41% | New | |
| 49 |
|
4.00M | $9.24M | 0.41% | Hold | |
| 50 |
|
250.00K | $8.74M | 0.39% | Hold | |
FAQ
What did Siren, L.L.C. buy in 2024-Q4?
In its 2024-Q4 13F filing, Siren, L.L.C. reported 117 equity positions worth $2.26B in aggregate; its largest disclosed positions were SRRK ($399.79M), ONC ($120.75M), KYMR ($119.47M).
How large is Siren, L.L.C.'s portfolio?
Siren, L.L.C. reported $2.26B of long equity holdings across 117 positions as of 2024-Q4. Top-10 holdings account for 48.6% of reported value.
What is Siren, L.L.C.'s investment style?
HoldingsHub classifies the portfolio as Mid / Health Tilt / High Turnover, computed from size, concentration, sector tilt and turnover.
Where does this data come from?
All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.